[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …

J Prattes, J Wauters, DR Giacobbe… - Clinical Microbiology …, 2022 - Elsevier
Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis

C Shi, Q Shan, J Xia, L Wang, L Wang, L Qiu, Y Xie… - Mycoses, 2022 - Wiley Online Library
Background An increasing number of cases of invasive pulmonary aspergillosis (IPA)
complicating influenza have been described. We performed a meta‐analysis to estimate the …

[HTML][HTML] Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

S Hatzl, AC Reisinger, F Posch, J Prattes, M Stradner… - Critical Care, 2021 - Springer
Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary
aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …

[HTML][HTML] Clinical manifestations of human exposure to fungi

M Oliveira, D Oliveira, C Lisboa, JL Boechat… - Journal of Fungi, 2023 - mdpi.com
Biological particles, along with inorganic gaseous and particulate pollutants, constitute an
ever-present component of the atmosphere and surfaces. Among these particles are fungal …

Prognostic impact of bronchoalveolar lavage fluid galactomannan and aspergillus culture results on survival in COVID-19 intensive care unit patients: a post hoc …

DR Giacobbe, J Prattes, J Wauters… - Journal of clinical …, 2022 - Am Soc Microbiol
Critically ill patients with coronavirus disease 2019 (COVID-19) may develop COVID-19-
associated pulmonary aspergillosis (CAPA), which impacts their chances of survival …

[HTML][HTML] COVID-19-associated pulmonary aspergillosis in a tertiary hospital

GC Marta, FE Lorena, MV Laura, LM Angela… - Journal of Fungi, 2022 - mdpi.com
Our study aims to assess the prevalence of CAPA (COVID-19-associated pulmonary
aspergillosis) and describe the associated risk factors and their impact on mortality. A …

Point-of-care testing for viral-associated pulmonary aspergillosis

R Aerts, B Autier, M Gornicec, J Prattes… - Expert Review of …, 2024 - Taylor & Francis
Introduction Over the last years, severe respiratory viral infections, particularly those caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the influenza virus …

[HTML][HTML] AWMF mold guideline “Medical clinical diagnostics for indoor mold exposure”–Update 2023 AWMF Register No. 161/001

J Hurraß, B Heinzow, S Walser-Reichenbach… - Allergologie …, 2024 - ncbi.nlm.nih.gov
The guideline is aimed at allergists, occupational physicians, ENT physicians, hygienists,
immunologists, hospital hygienists, medical mycologists, pulmonologists, and environmental …

Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations

TM Rawson, DB Antcliffe, RC Wilson… - Infection and drug …, 2023 - Taylor & Francis
Bacterial and fungal infections are common issues for patients in the intensive care unit
(ICU). Large, multinational point prevalence surveys have identified that up to 50% of ICU …

[HTML][HTML] COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening Aspergillus fumigatus Infection?

T Peláez-García de la Rasilla, I González-Jiménez… - Journal of Fungi, 2022 - mdpi.com
Most cases of invasive aspergillosis are caused by Aspergillus fumigatus, whose conidia are
ubiquitous in the environment. Additionally, in indoor environments, such as houses or …